In conclusion, in this report, we have provided data showing that the function and ligand-dependent activity of ERβ, as an ovarian tumor cell growth inhibitor, is dependent of posttranslational acetylation and that the level of KDM6B and the NAD+-dependent deacetylase SIRT1 play important roles in this process. Here, KDM6B is linked to ovarian neoplasm.